Sisyphus, the Giffen's paradox and the Holy Grail: Time for organ transplantation to transition toward a regenerative medicine-focused type of research

Expert Review of Clinical Immunology

Volumn 9, Issue 10, 2013, Pages 883-885

  Peloso, Andrea ^a   Katari, Ravi ^a   Zambon, Joao P ^a   Orlando, Giuseppe ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

immunosuppression; organs; regenerative medicine; tolerance; transplantation

Indexed keywords

AUTOTRANSPLANTATION; BIOENGINEERING; CLINICAL RESEARCH; EDITORIAL; ORGAN TRANSPLANTATION; REGENERATIVE MEDICINE;

ANIMALS; HUMANS; ORGAN TRANSPLANTATION; REGENERATIVE MEDICINE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84886926369     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2013.828887     Document Type: Editorial

References (14)

1. Bachelard G. La Philosophie du Non (4th Edition). Les Presses Universitaires de France, Paris, France. (1966).
2. Orlando G, Soker S, Stratta RJ. Organ bioengineering and regeneration as the new Holy Grail for organ transplantation. Ann. Surg. 258(2), 221-232 (2013).
3. Orlando G, Domínguez-Bendala J, Shupe T et al. Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut 62(5), 774-786 (2013).
4. Orlando G, Wood KJ, De Coppi P et al. Regenerative medicine as applied to general surgery. Ann. Surg. 255(5), 867-880 (2012).
5. Orlando G, Wood KJ, Stratta RJ, Yoo J, Atala A, Soker S. Regenerative medicine and organ transplantation: past, present and future. Transplantation 91(12), 1310-1317 (2011).
6. Orlando G, Baptista P, Birchall M et al. Regenerative medicine as applied to solid organ transplantation: current status and future development. Transpl. Int. 24(3), 223-232 (2011).
7. Orlando G. Transplantation as a subfield of regenerative medicine. Interview by Lauren Constable. Expert Rev. Clin. Immunol. 7(2), 137-141 (2011).
8. Orlando G, Hematti P, Stratta RJ et al. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann. Surg. 252(6), 913-926 (2010).
9. Orlando G. Finding the right time for weaning off immunosuppression in solid organ transplant recipients. Expert Rev. Clin. Immunol. 6(6), 879-892 (2010).
10. Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J. Hepatol. 50(6), 1247-1257 (2009).
11. Orlando G, Wood KJ, Soker S, Stratta RJ. How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation 92(8), e36-e38 (2011).
12. Thomas L. Notes of a Biology-Watcher: the technology of medicine. N. Eng. J. Med. 285(24), 1366-1368 (1971).
13. Rubín A, Aguilera V, Berenguer M. Liver transplantation and hepatitis C. Clin. Res. Hepatol. Gastroenterol. 35(12), 805-812 (2011).
14. Orlando G, Booth CL, Wang Z et al. Discarded human kidneys as a source of ECM scaffolds for kidney regeneration technologies. Biomaterials 34(24), 5915-5925 (2013).